Showing results (31-40 of 692) with videos related to

Sort By:
Pageof 70
The American Journal of Surgical Pathology|June 8, 2023
Blastoid and Pleomorphic Mantle Cell Lymphoma Demonstrate Distinct Clinicopathologic and Genetic FeaturesMahsa Khanlari, Huan Mo, Do Hwan Kim, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 13, 2021
Computer-aided detection of mantle cell lymphoma on 18F-FDG PET/CT using a deep learning convolutional neural networkZijian Zhou, Preetesh Jain, Yang Lu, et al.
Cell Death & Disease|November 3, 2023
Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteinsYijing Li, Heng-Huan Lee, Vivian Changying Jiang, et al.
Blood Advances|July 11, 2019
Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphomaMatthew S Ning, Chelsea C Pinnix, Bhavana V Chapman, et al.
Blood|January 10, 2015
Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinibPreetesh Jain, Michael Keating, William Wierda, et al.
Cancer|February 8, 2017
Long-term outcomes for patients with chronic lymphocytic leukemia who discontinue ibrutinibPreetesh Jain, Philip A Thompson, Michael Keating, et al.
Leukemia & Lymphoma|May 25, 2019
Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapyPrajwal Boddu, Preetesh Jain, Gautam Borthakur, et al.
Cancer|July 22, 2014
FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemiaPreetesh Jain, Hun Ju Lee, Wei Qiao, et al.
Cancer Genetics|December 25, 2022
Clinical impact of 5'MYC or 3'MYC gain/loss detected by FISH in patients with aggressive B-cell lymphomasGuilin Tang, Shaoying Li, Gokce A Toruner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Long-term Follow-up of Treatment with Ibrutinib and Rituximab in Patients with High-Risk Chronic Lymphocytic LeukemiaPreetesh Jain, Michael J Keating, William G Wierda, et al.
Pageof 70